Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001830914-26-000004
Filing Date
2026-05-12
Accepted
2026-05-12 16:30:27
Documents
1
Period of Report
2026-05-09

Document Format Files

Seq Description Document Type Size
1 form4-05122026_040514.html 4  
1 form4-05122026_040514.xml 4 4163
  Complete submission text file 0001830914-26-000004.txt   5752
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O IN8BIO, INC. 79 MADISON AVENUE NEW YORK NY 10016
Business Address
Ho William Tai-Wei (Reporting) CIK: 0001830914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 26969119